Cytotoxic autophagy in cancer therapy

International Journal of Molecular Sciences

Volumn 15, Issue 6, 2014, Pages 10034-10051

  Sharma, Khushboo ^a   Le, Ngoc ^a   Alotaibi, Moureq ^a   Gewirtz, David A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Apoptosis; Autophagy; Chemotherapy; Radiation

Indexed keywords

ANACARDIC ACID; AUTOPHAGY PROTEIN 5; BECLIN 1; CALCITRIOL; CANNABIDIOL; CISPLATIN; DNA DEPENDENT PROTEIN KINASE; DOXORUBICIN; EVEROLIMUS; GLUCOSE REGULATED PROTEIN 78; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN; RESVERATROL; TEMOZOLOMIDE; TRIFLUOPERAZINE; ANTINEOPLASTIC AGENT;

AUTOPHAGOSOME; AUTOPHAGY; BRAIN CANCER; BREAST TUMOR; CANCER THERAPY; CELL DEATH; ENDOPLASMIC RETICULUM STRESS; FLUORESCENCE ACTIVATED CELL SORTING; GLIOBLASTOMA; HUMAN; LUNG NON SMALL CELL CANCER; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; NONHUMAN; REVIEW; ANIMAL; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; BREAST; BREAST NEOPLASMS; DRUG EFFECTS; FEMALE; LUNG; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; RADIATION RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BRAIN; BRAIN NEOPLASMS; BREAST; BREAST NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; LUNG; LUNG NEOPLASMS;

EID: 84901999801     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150610034     Document Type: Review

References (93)

1. Eisenberg-Lerner, A.; Bialik, S.; Simon, H.-U.; Kimchi, A. Life and death partners: Apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009, 16, 966-975.
2. Denton, D.; Nicolson, S.; Kumar, S. Cell death by autophagy: Facts and apparent artefacts. Cell Death Differ. 2012, 19, 87-95.
3. Vakifahmetoqlu, H.; Olsson, M.; Zhivotovsky, B. Death through a tragedy: Mitotic catastrophe. Cell Death Differ. 2008, 15, 1153-1162.
4. Vandenabeele, P.; Galluzzi, L.; Berghe, V.T.; Kroemer, G. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 2010, 11, 700-714.
5. Scarlatti, F.; Granata, R.; Meijer, A.J.; Codogno, P. Does autophagy have a license to kill mammalian cells? Cell Death Differ. 2009, 16, 12-20.
6. Chen, H.Y.; White, E. Role of autophagy in cancer prevention. Cancer Prev. Res. 2011, 4, 973-983.
7. Murrow, L.; Debnath, J. Autophagy as a stress-response and quality-control mechanism: Implications for cell injury and human disease. Annu. Rev. Pathol. Mech. Dis. 2013, 8, 105-137.
8. Shen, H.M.; Codogno, P. Autophagic cell death: Loch Ness monster or endangered species? Autophagy 2011, 7, 457-465.
9. Gewirtz, D.A. The four faces of autophagy: Implications for cancer therapy. Cancer Res. 2014, 74, 647-651.
10. Gewirtz, D.A. When cytoprotective autophagy isn't... and even when it is. Autophagy 2014, 10, 391-392.
11. Shen, S.; Kepp, O.; Michaud, M.; Martins, I.; Minoux, H.; Métivier, D.; Maiuri, M.C.; Kroemer, R.T.; Kroemer, G. Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 2011, 30, 4544-4556.
12. Hu, Y.L.; Jahangiri, A.; Delay, M.; Aghi, M.K. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy. Cancer Res. 2012, 72, 4294-4299.
13. Zou, Z.; Yuan, Z.; Zhang, Q.; Long, Z.; Chen, J.; Tang, Z.; Zhu, Y.; Chen, S.; Xu, J.; Yan, M.; et al. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy 2012, 8, 1798-1810.
14. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
15. Yao, Q.; Chen, J.; Lv, Y.; Wang, T.; Zhang, J.; Fan, J.; Wang, L. The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumor Biol. 2011, 32, 1163-1171.
16. Scarlatti, F.; Maffei, R.; Beau, I.; Codogno, P.; Ghidoni, R. Role of non-canonical Beclin1-independent autophagy in cell death by resveratrol in human breast cancer cells. Cell Death Differ. 2008, 15, 1318-1329.
17. Akar, U.; Chaves-Reyez, A.; Barria, M.; Tari, A.; Sangguino, A.; Kondo, Y.; Kondo, S.; Arun, B.; Lopez-Berestein, G.; Ozpolat, B. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008, 4, 669-679.
18. Zeng, X.; Overmeyer, J.H.; Maltese, W.A. Functional specificity of the mammalian Beclin-Vcp34 PI3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J. Cell Sci. 2006, 119, 259-270.
19. Thorburn, A. Apoptosis and autophagy: Regulatory connections between two supposedly different processes. Apoptosis 2008, 13, 1-9.
20. Shrivastava, A.; Kuzontkoski, P.M.; Groopman, J.E.; Prasad, A. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol. Cancer Ther. 2011, 10, 1161-1172.
21. Yorimitsu, T.; Nair, U.; Yang, Z.; Klionsky, D. Endoplasmic reticulum stress triggers autophagy. J. Biol. Chem. 2006, 281, 30299-30304.
22. Vandenabeele, P.; Vanden, B.T.; Festjens, N. Caspase inhibitiors promote alternative cell death pathways. Sci. STKE 2006, 2006, doi:10.1126/stke.3582006pe44.
23. Di, X.; Robert, P.S.; Irene, F.N.; Gewirtz, D.A. Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to Adriamycin. Biochem. Pharmacol. 2009, 77, 1139-1150.
24. Wilson, E.N.; Bristol, M.L.; Di, X.; Maltese, W.A.; Koterba, K.; Beckman, M.J.; Gewirtz, D.A. A switch between cytoprotective and cytotoxic autophagy in the radio sensitization of breast tumor cells by chloroquine and vitamin D. Horm. Cancer 2011, 2, 272-285.
25. 3. Autophagy 2012, 8, 739-753.
26. Ito, H.; Daido, S.; Kanzawa, T.; Kondo, S.; Kondo, Y. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int. J. Oncol. 2005, 26, 1401-1410.
27. Lomonaco, S.L.; Finniss, S.; Xiang, C.; Decarvalho, A.; Umansky, F.; Kalkanis, S.N.; Mikkelsen, T.; Brodie, C. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int. J. Cancer 2009, 125, 717-722.
28. Apel, A.; Herr, I.; Schwarz, H.; Rodemann, H.P.; Mayer, A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008, 68, 1485-1494.
29. Lungcancer. org. Available online: http://www.Lungcancer.org (accessed on 21 May 2014).
30. Sharieff, W.; Okawara, G.; Tsakiridis, T.; Wright, J. Predicting 2-year survival for radiation regimens in advanced non-small cell lung cancer. Clin. Oncol. 2013, 25, 697-705.
31. Saintigny, P.; Burger, J.A. Recent advances in non-small cell lung cancer biology and clinical management. Discov. Med. 2012, 13, 287-297.
32. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics. CA Cancer J. Clin. 2013, 63, 11-30.
33. Ko, A.; Kanehisa, A.; Martins, I.; Senovilla, L.; Chargari, C.; Dugue, D.; Marino, G.; Kepp, O.; Michaud, M.; Perfettini, J.L.; et al. Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signaling. Cell Death Differ. 2013, 21, 92-99.
34. Cheng, G.; Kong, D.; Hou, X.; Liang, B.; He, M.; Liang, N.; Ma, S.; Liu, X. The Tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis. Cancer Biother. Radiopharm. 2013, 28, 153-159.
35. Peng, P.L.; Kuo, W.H.; Tseng, H.C.; Chou, F.P. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: The contribution of autophagic cell death. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70, 529-542.
36. Shin, J.Y.; Lim, H.T.; Minai-Tehrani, A.; Noh, M.S.; Kim, J.E.; Kim, J.H.; Jiang, J.H.; Arote, R.; Kim, D.Y.; Chae, C.; et al. Aerosol delivery of beclin-1 enhanced the anti-tumor effect of radiation in the lungs of k-ras LA1 mice. J. Radiat. Res. 2012, 53, 506-515.
37. Seong, Y.A.; Shin, P.G.; Yoon, J.S.; Yadunandam, A.K.; Kim, G.D. Induction of the Endoplasmic Reticulum stress and autophagy in human lung carcinoma A549 cells by Anacardic Acid. Cell Biochem. Biophys. 2014, 68, 369-377.
38. Li, J.; Ni, M.; Lee, B.; Barron, E.; Hinton, D.R.; Lee, A.S. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress induced autophagy in mammalian cells. Cell Death Differ. 2008, 15, 1460-1471.
39. Gozuacik, D.; Bialik, S.; Raveh, T.; Mitou, G.; Shohat, G.; Sabanay, H.; Mizushima, N.; Yoshimori, T.; Kimchi, A. DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ. 2008, 15, 1875-1886.
40. Zalckvar, E.; Berissi, H.; Mizrachy, L.; Idelchuk, Y.; Koren, I.; Eisenstein, M.; Sabanay, H.; Pinkas-Kramarski, R.; Kimchi, A. DAP-kinase mediated phosphorylation on BH3 domain of beclin 1 promotes dissociation of beclin-1 from Bcl-XL and induction of autophagy. EMBO Rep. 2009, 10, 285-292.
41. Kim, K.W.; Hwang, M.; Moretti, L.; Jaboin, J.J.; Cha, Y.I.; Lu, B. Autophagy up-regulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 2008, 4, 659-668.
42. Kim, K.W.; Mutter, R.W.; Cao, C.; Albert, J.M.; Freeman, M.; Hallahan, D.E.; Lu, B. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J. Biol. Chem. 2006, 281, 36883-36890.
43. Scherl-Mostageer, M.; Sommergruber, W.; Abseher, R.; Hauptmann, R.; Ambros, P.; Schweifer, N. Identification of a novel gene. CDCP1, overexpressed in human colorectal cancer. Oncogene 2001, 20, 4402-4408.
44. Buhring, H.J.; Kuci, S.; Conze, T.; Rathke, G.; Bartolovic, K.; Grunebach, F.; Scherl-Mostageer, M.; Brummendorf, T.H.; Schweifer, N.; Lammers, R. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cells subsets of hematopoietic and nonhematopoietic origin. Stem Cells 2004, 22, 334-343.
45. Uekita, T.; Jia, L.; Narisawa-Saito, M.; Yokota, J.; Kiyono, T.; Sakai, R. CUB domain-containing protein I is a novel regulator of anoikis resistance lung adenocarcinoma. Mol. Cell. Biol. 2007, 27, 7649-7660.
46. Miyazawa, Y.; Uekita, T.; Hiraoka, N.; Fujii, S.; Kosuqe, T.; Kanao, Y.; Nojima, Y.; Sakai, R. CUB domain-containing protein 1 a progenitor factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res. 2010, 70, 5136-5146.
47. Frish, S.M.; Screaton, R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 2001, 13, 555-562.
48. Miyazawa, Y.; Uekita, T.; Ito, Y.; Seiki, M.; Yamaguchi, H.; Sakai, R. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells. Mol. Cancer Res. 2013, 11, 628-637.
49. Rothbart, S.B.; Racanelli, A.C.; Moran, R.G. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas. Cancer Res. 2010, 70, 10299-10309.
50. Bareford, M.D.; Park, M.A.; Yacoub, A.; Hamed, H.A.; Tang, Y.; Cruickshanks, N.; Eulitt, P.; Hubbard, N.; Tye, G.; Burow, M.E.; et al. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Res. 2011, 71, 4955-4967.
51. Khan, M.I.; Mohammad, A.; Patil, G.; Naqvi, S.A.; Chauhan, L.K.; Ahmad, I. Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials 2012, 33, 1477-1488.
52. Meijer, A.J.; Codogno, P. AMP-activated protein kinase and autophagy. Autophagy 2007, 3, 238-240.
53. Kim, E.J.; Jeong, J.H.; Bae, S.; Kang, S.; Kim, C.H.; Lim, Y.B. mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy. J. Cell. Biochem. 2012, 114, 1248-1256.
54. Gao, W.; Shen, Z.; Shang, L.; Wang, X. Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death. Cell Death Differ. 2011, 18, 1598-1607.
55. Jung, C.H.; Jun, C.B.; Ro, S.H.; Kim, Y.M.; Otto, N.M.; Cao, J.; Kundu, M.; Kim, D.H. ULK-ATG13-FIP200 complexes mediate mTOR signaling to autophagy machinery. Mol. Biol. Cell 2009, 20, 1992-2003.
56. Sirichanchuen, B.; Pengsuparp, T.; Chanvorachote, P. Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells. Mol. Cell. Biochem. 2012, 364, 11-18.
57. Pattingre, S.; Tassa, A.; Qu, X.; Garuti, R.; Liang, X.H.; Mizushima, N.; Packer, M.; Schneider, M.D.; Levine, B. Bcl-2 antiapoptotic proteins inhibit Beclin-1 dependent autophagy. Cell 2005, 122, 927-939.
58. Lefranc, F.; Brotchi, J.; Kiss, R. Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol. 2005, 23, 2411-2422.
59. Stupp, R.; Mason, W.P.; van den Bent, M.J.; Weller, M.; Fisher, B.; Taphoorn, M.J.; Belanger, K.; Brandes, A.A.; Marosi, C.; Bogdahn, U.; et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352, 987-996.
60. Newton, H.B. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: Pi3k/akt/pten, mtor, shh/ptch and angiogenesis. Expert Rev. Anticancer Ther. 2004, 4, 105-128.
61. Knobbe, C.B.; Reifenberger, G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase b (akt) signal transduction pathway in glioblastomas. Brain Pathol. 2003, 13, 507-518.
62. Kapoor, G.S.; O'Rourke, D.M. Mitogenic signaling cascades in glial tumors. Neurosurgery 2003, 52, 1425-1435.
63. Joy, A.M.; Beaudry C.E.; Tran, N.L.; Ponce, F.A.; Holz, D.R.; Demuth, T.; Berens M.E. Migrating glioma cells activate the pi3-k pathway and display decreased susceptibility to apoptosis. J. Cell Sci. 2003, 116, 4409-4417.
64. Shingu, T.; Yamada, K.; Hara, N.; Moritake, K.; Osago, H.; Terashima, M.; Uemura, T.; Yamasaki, T.; Tsuchiya, M. Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells. Cancer Res. 2003, 63, 4044-4047.
65. Lefranc, F.; Sadeghi, N.; Camby, I.; Metens, T.; Dewitte, O.; Kiss, R. Present and potential future issues in glioblastoma treatment. Expert Rev. Anticancer Ther. 2006, 6, 719-732.
66. Takeuchi, H.; Kondo, Y.; Fujiwara, K.; Kanzawa, T.; Aoki, H.; Mills, G.B.; Kondo, S. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase b inhibitors. Cancer Res. 2005, 65, 3336-3346.
67. Fan, Q.W.; Weiss, W.A. Autophagy and akt promote survival in glioma. Autophagy 2011, 7, 536-538.
68. Gupta, A.K.; Bakanauskas, V.J.; Cerniglia G.J.; Cheng, Y.; Bernhard, E.J.; Muschel, R.J.; McKenna, W.G. The Ras radiation resistance pathway. Cancer Res. 2001, 61, 4278-4282.
69. Gupta, A.K.; McKenna, W.G.; Weber C.N.; Feldman, M.D.; Goldsmith, J.D.; Mick, R.; Machtay, M.; Rosenthal, D.I.; Bakanauskas, V.J.; Cerniglia, G.J.; et al. Local recurrence in head and neck cancer: Relationship to radiation resistance and signal transduction. Clin. Cancer Res. 2002, 8, 885-892.
70. Gupta, A.K.; Bernhard, E.J.; Bakanauskas, V.J.; Wu, J.; Muschel, R.J.; McKenna, W.G. RAS-mediated radiation resistance is not linked to MAP kinase activation in two bladder carcinoma cell lines. Radiat. Res. 2000, 154, 64-72.
71. Kim, I.A.; Bae, S.S.; Fernandes, A.; Wu, J.; Muschel, R.J.; McKenna, W.G.; Birnbaum, M.J.; Bernhard, E.J. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines. Cancer Res. 2005, 17, 7902-7910.
72. West, K.A.; Castillo, S.S.; Dennis, P.A. Activation of the pi3k/akt pathway and chemotherapeutic resistance. Drug Resist. Updat. 2002, 5, 234-248.
73. Hennessy, B.T.; Smith, D.L.; Ram, P.T.; Lu, Y.; Mills, G.B. Exploiting the pi3k/akt pathway for cancer drug discovery. Nat. Rev. Drug Discov. 2005, 4, 988-1004.
74. Fujiwara, K.; Iwado, E.; Mills, G.B.; Sawaya, R.; Kondo, S.; Kondo, Y. Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy. Int. J. Oncol. 2007, 31, 753-760.
75. Ito, H.; Aoki, H.; Kuhnel, F.; Kondo, Y.; Kubicka, S.; Wirth, T.; Iwado, E.; Iwamaru, A.; Fujiwara, K.; Hess, K.R.; et al. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J. Natl. Cancer Inst. 2006, 98, 625-636.
76. Jiang, H.; Gomez-Manzano, C.; Aoki, H.; Alonso, M.M.; Kondo, S.; McCormick, F.; Xu, J.; Kondo, Y.; Bekele, B.N.; Colman, H.; et al. Examination of the therapeutic potential of delta-24-rgd in brain tumor stem cells: Role of autophagic cell death. J. Natl. Cancer Inst. 2007, 99, 1410-1414.
77. Zhou, W.; Sun, M.; Li, G.H.; Wu, Y.Z.; Wang, Y.; Jin, F.; Zhang, Y.Y.; Yang, L.; Wang, D.L. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells. Oncol. Rep. 2013, 30, 1793-1801.
78. Short, S.C.; Martindale, C.; Bourne, S.; Brand, G.; Woodcock, M.; Johnston, P. DNA repair after irradiation in glioma cells and normal human astrocytes. Neuro Oncol. 2007, 9, 404-411.
79. Naidu, M.D.; Mason, J.M.; Pica, R.V.; Fung, H.; Peña, L.A. Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1. J. Radiat. Res. 2010, 51, 393-404.
80. Smith, G.C.; Jackson, S.P. The DNA-dependent protein kinase. Genes Dev. 1999, 13, 916-934.
81. Daido, S.; Yamamoto, A.; Fujiwara, K.; Sawaya, R.; Kondo, S.; Kondo, Y. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res. 2005, 65, 4368-4375.
82. Zhuang, W.; Li, B.; Long, L.; Chen, L.; Huang, Q.; Liang, Z.Q. Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy. Brain Res. 2011, 1371, 7-15.
83. Chan, D.W.; Ye, R.; Veillette, C.J.; Lees-Miller, S.P. DNA-dependent protein kinase phosphorylation sites in ku 70/80 heterodimer. Biochemistry 1999, 38, 1819-1828.
84. Yu, Y.; Wang, W.; Ding, Q.; Ye, R.; Chen, D.; Merkle, D.; Schriemer, D.; Meek, K.; Lees-Miller, S.P. DNA-pk phosphorylation sites in xrcc4 are not required for survival after radiation or for v(d)j recombination. DNA Repair (Amst.). 2003, 2, 1239-1252.
85. Woo, R.A.; McLure, K.G.; Lees-Miller, S.P.; Rancourt, D.E.; Lee, P.W. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 1998, 394, 700-704.
86. Mayo, L.D.; Turchi, J.J.; Berberich, S.J. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. Cancer Res. 1997, 57, 5013-5016.
87. Kharbanda, S.; Pandey, P.; Jin, S.; Inoue, S.; Bharti, A.; Yuan, Z.M.; Weichselbaum, R.; Weaver, D.; Kufe, D. Functional interaction between DNA-pk and c-abl in response to DNA damage. Nature 1997, 386, 732-735.
88. Yung, W.K.; Albright, R.E.; Olson, J.; Fredericks, R.; Fink, K.; Prados, M.D.; Brada, M.; Spence, A.; Hohl, R.J.; Shapiro, W.; et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br. J. Cancer. 2000, 83, 588-593.
89. Roos, W.P.; Batista, L.F.; Naumann, S.C.; Wick, W.; Weller, M.; Menck, C.F.; Kaina, B. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 2007, 26, 186-197.
90. Hegi, M.E.; Diserens, A.C.; Gorlia, T.; Hamou, M.F.; de Tribolet, N.; Weller, M.; Kros, J.M.; Hainfellner, J.A.; Mason, W.; Mariani, L.; et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 2005, 352, 997-1003.
91. Kanzawa, T.; Bedwell, J.; Kondo, Y.; Kondo, S.; Germano, I.M. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. J. Neurosurg. 2003, 99, 1047-1052.
92. Kanzawa, T.; Germano, I.M.; Komata, T.; Ito, H.; Kondo, Y.; Kondo, S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004, 11, 448-457.
93. Palumbo, S.; Pirtoli, L.; Tini, P.; Cevenini, G.; Calderaro, F.; Toscano, M.; Miracco, C.; Comincini, S. Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. J. Cell. Biochem. 2012, 113, 2308-2318.